Compare, Analyse IPCA Labs with MYLAN INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

IPCA LABS vs MYLAN (US) - Comparison Results

IPCA LABS     Change

Ipca Laboratories is an integrated pharmaceutical company with presence in intermediates, APIs and formulations. The company has a strong focus on exports, catering to the US, Europe and the semi-regulated markets of the CIS, Africa and Asia. The com... More

MYLAN (US)
   Change

Mylan is one of the worlds leading generics and specialty pharmaceutical company. Its products span to customers in about 140 countries across the world. The company maintains one of the industrys broadest and highest quality product portfolios, wh... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 IPCA LABS   MYLAN
EQUITY SHARE DATA
    IPCA LABS
Mar-19
MYLAN
Dec-18
IPCA LABS/
MYLAN
5-Yr Chart
Click to enlarge
High Rs1,0423,493-   
Low Rs5901,923-   
Sales per share (Unadj.) Rs298.61,607.2-  
Earnings per share (Unadj.) Rs35.043.6-  
Cash flow per share (Unadj.) Rs49.4344.6-  
Dividends per share (Unadj.) Rs3.000-  
Dividend yield (eoy) %0.40-  
Book value per share (Unadj.) Rs247.11,738.7-  
Shares outstanding (eoy) m126.35514.50-   
Bonus/Rights/Conversions ESOS--  
Price / Sales ratio x2.71.7 162.2%   
Avg P/E ratio x23.362.0 37.6%  
P/CF ratio (eoy) x16.57.9 210.1%  
Price / Book Value ratio x3.31.6 212.0%  
Dividend payout %8.60-   
Avg Mkt Cap Rs m103,1081,393,123 7.4%   
No. of employees `00013.435.0 38.4%   
Total wages/salary Rs m7,8740-   
Avg. sales/employee Rs Th2,807.023,626.3 11.9%   
Avg. wages/employee Rs Th585.80-   
Avg. net profit/employee Rs Th329.0641.6 51.3%   
INCOME DATA
Net Sales Rs m37,732826,919 4.6%  
Other income Rs m5770-   
Total revenues Rs m38,309826,919 4.6%   
Gross profit Rs m6,901213,976 3.2%  
Depreciation Rs m1,824154,832 1.2%   
Interest Rs m18939,772 0.5%   
Profit before tax Rs m5,46519,372 28.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,042-3,082 -33.8%   
Profit after tax Rs m4,42222,454 19.7%  
Gross profit margin %18.325.9 70.7%  
Effective tax rate %19.1-15.9 -119.9%   
Net profit margin %11.72.7 431.6%  
BALANCE SHEET DATA
Current assets Rs m23,778461,751 5.1%   
Current liabilities Rs m10,975336,667 3.3%   
Net working cap to sales %33.915.1 224.3%  
Current ratio x2.21.4 158.0%  
Inventory Days Days10484 124.2%  
Debtors Days Days6693 70.6%  
Net fixed assets Rs m20,368160,409 12.7%   
Share capital Rs m253440 57.4%   
"Free" reserves Rs m30,9710-   
Net worth Rs m31,224894,576 3.5%   
Long term debt Rs m1,409965,534 0.1%   
Total assets Rs m45,5072,399,599 1.9%  
Interest coverage x30.01.5 2,014.6%   
Debt to equity ratio x01.1 4.2%  
Sales to assets ratio x0.80.3 240.6%   
Return on assets %10.12.6 390.7%  
Return on equity %14.22.5 564.2%  
Return on capital %17.33.2 544.9%  
Exports to sales %45.90-   
Imports to sales %16.60-   
Net fx Rs m11,0420-   
CASH FLOW
From Operations Rs m4,923171,834 2.9%  
From Investments Rs m-1,563-88,819 1.8%  
From Financial Activity Rs m-1,832-80,050 2.3%  
Net Cashflow Rs m1,5281,424 107.3%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for MYLAN (US) is United States Dollars. All data has been converted at 73.38 Rs / USD

Compare IPCA LABS With: ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  

Compare IPCA LABS With: BIOCON   WOCKHARDT  SHASUN PHARMA  ALKEM LABORATORIES  DIVIS LABORATORIES  



Today's Market

Sensex Falls 471 Points, Nifty Ends Below 14,700; Tata Steel & JSW Steel Top Losers(Closing)

Indian share markets witnessed selling pressure throughout the day today and ended lower.

Related Views On News

IPCA LABS Announces Quarterly Results (3QFY21); Net Profit Up 32.2% (Quarterly Result Update)

Feb 5, 2021 | Updated on Feb 5, 2021

For the quarter ended December 2020, IPCA LABS has posted a net profit of Rs 3 bn (up 32.2% YoY). Sales on the other hand came in at Rs 13 bn (up 15.5% YoY). Read on for a complete analysis of IPCA LABS's quarterly results.

IPCA LABS Announces Quarterly Results (1QFY21); Net Profit Up 243.5% (Quarterly Result Update)

Sep 29, 2020 | Updated on Sep 29, 2020

For the quarter ended June 2020, IPCA LABS has posted a net profit of Rs 5 bn (up 243.5% YoY). Sales on the other hand came in at Rs 15 bn (up 46.9% YoY). Read on for a complete analysis of IPCA LABS's quarterly results.

What's Behind the Rally in Pharma Stocks? (Views On News)

May 11, 2021

The second wave of Covid has given a new lease of life to pharma stocks.

Why Did Alembic Pharma Shares Fall Today? (Views On News)

May 5, 2021

Covid-led supply disruptions of API fuel Alembic Pharma's global prospects.

More Views on News

Most Popular

The Next Smallcap Winners (Profit Hunter)

Apr 30, 2021

Price is the only due diligence one might require to buy this business.

Time to Buy Smallcaps? (Fast Profits Daily)

Apr 30, 2021

In this video, I'll show you why I favour smallcaps over the Nifty.

Are the Stock Markets Deaf to Covid Agony? (Profit Hunter)

May 6, 2021

Why are markets discounting the economic impact of Covid?

My Secret to Find Breakthrough Stocks (Fast Profits Daily)

May 7, 2021

I've used this trading technique for many years with great success. I'm sharing it with you today.

More
-->

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

FREE Event: Discover Your First Stock for a Potential Rs 7 Crore in Long-term Wealth
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
Covid-19 Proof Multibagger Stocks - Download this FREE Report Now
Free Report: The Secret to Increasing Your Trading Profits Daily!
No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.

IPCA LABS SHARE PRICE


May 12, 2021 (Close)

TRACK IPCA LABS

  • Track your investment in IPCA LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON IPCA LABS

IPCA LABS - NATCO PHARMA COMPARISON

COMPARE IPCA LABS WITH

FEATURED VIDEOS

The 'Big' Money is in this 'Small' Detail

Stability, Quality or Green Stocks for 2021?

Market Crash: Picture Abhi Baaki Hai?

It's a Great Time to Buy Gold

More Featured Videos

MARKET STATS